Vaximm
Pre-clinicalDevelops T-cell activating cancer vaccines targeting solid tumors.
Founded
2009
Focus
Biologics
About
Develops T-cell activating cancer vaccines targeting solid tumors.
Funding History
3Total raised: $32.5M
Grant$2.5MEuropean CommissionMar 15, 2020
Series B$20MBioMedPartnersJun 15, 2018
Series A$10MBoehringer Ingelheim Venture FundJan 15, 2015
Company Info
TypePrivate
Founded2009
LocationBasel, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile